Chongqing Lummy Pharmaceutical Co., Ltd.
SHZ: 300006.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Rongzhao Qiu
- Employees
- 1,019
- Headquarters
- Chongqing, China
- IPO year
- 2009
- Market cap
- CN¥6.6B
- Website
- https://www.cqlummy.com
Loading 300006…
Loading profile data…Frequently asked questions about 300006
What does Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) do?
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system,...
Where does 300006.SZ trade?
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300006.SZ in?
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Chongqing Lummy Pharmaceutical Co., Ltd.?
Rongzhao Qiu is the chief executive officer of Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ).
Where is Chongqing Lummy Pharmaceutical Co., Ltd. headquartered?
Chongqing Lummy Pharmaceutical Co., Ltd. is headquartered in China.
Does 300006.SZ pay a dividend?
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 300006.SZ go public?
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) completed its initial public offering in 2009.